Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Clinical Impact of Stent Design
Author(s): Rebecca L Noad , Colm Hanratty , Simon J Walsh Added: 3 years ago
As the role of percutaneous coronary intervention (PCI) has evolved, inevitably, so too has the technology associated with this specialty. Initially, plain old balloon angioplasty (POBA) was developed as a strategy to ‘stretch’ focal stenoses within the coronary arteries leading to a relief from ischaemia and angina. Whilst potentially of great benefit to some patients, POBA was beset by a series… View more

Intervention
Research Area(s) / Expertise: Job title: Interventional Cardiologist
DrColm Hanratty is anInterventional Cardiologist atMater Private Hospital, Dublin, IE. Prior to joining Mater Private Hospital,he was clinical lead within the Belfast Trust for 8 years. He has sub-specialty interest in the management of complex Percutaneous Coronary Intervention (PCI) and is internationally recognised as one of the leading interventionists in terms of complex and chronic total… View more
Author(s): Michael Tittelbach , Tobias Diener Added: 3 years ago
Since the introduction of drug-eluting stents (DES), physicians have tried to find a delicate balance between achieving a highly effective result without compromising the safety of the patient. Various concepts have been introduced into the marketplace in the attempt to identify the optimal combination of characteristics; however, until now very little attention has been paid to combining a… View more

MI/ACS

Intervention
CRT 2020: Duration of DAPT treatment in ST prevention
Author(s): Dean J Kereiakes Added: 4 years ago
Prof Dean J Kereiakes (The Lindner Research Center at The Christ Hospital, Cincinnati, OH, US) co-principal investigator of the DAPT Study, discusses the effectiveness of short-term DAPT in the prevention of stent thrombosis following stent implantation. Questions: 1. How does the duration of DAPT affect clinical outcomes? 2. Why is there a debate about DAPT duration? 3. What is the clinical… View more

Anticoagulation
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
In this issue of Interventional Cardiology Review, the structural section contains an excellent paper on alcohol septal ablation for hypertrophic cardiomyopathy, discussing both clinical and procedural issues. Clapp brings us up to date with a review of current indications for PFO closure and Bapat discusses the different outcomes and indications for Sapien and CoreValve TAVI procedures. Gafoor… View more

Intervention
Author(s): Dominic J Allocco , Mary V Jacoski , Barbara Huibregtse , et al Added: 3 years ago
Advances in drug-eluting stent technology have continued to improve clinical outcomes for patients undergoing percutaneous coronary intervention (PCI). The development of the platinum– chromium (PtCr) alloy and Element™ stent architecture (or platform) is the result of more than eight years of research and development by Boston Scientific Corporation (BSC; Natick, MA, US) and builds on a pedigree… View more

Prevention & Chronic Conditions
JIM 2020: Onyx ONE study
Author(s): Gennaro Sardella Added: 4 years ago
Dr Gennaro Sardella (Sapienza University of Rome, Rome, Italy) discusses data from the Onyx ONE study and its implications for clinical practice. The Onyx ONE study is a randomised controlled trial with Resolute Onyx™ DES in one month dual antiplatelet therapy (DAPT) for high-bleeding risk patients. Questions: 1. What are the Onyx ONE study aims? 2. Could you describe this study design and… View more

Anticoagulation
TCT 21: 5Y Outcomes From the BIO-RESORT trial | drug eluting stent
Author(s): Eline H Ploumen Added: 2 years ago
In this short video, Dr Eline H Ploumen (Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, NL) discusses the 5-yearoutcomesfrom the BIO-RESORT trial. The randomized trial compared the ultrathin-strut and very thin-strut biodegradable polymer DES to thin-strut durable polymer DES. At 1-year follow-up, non-inferiority of the two novel DES was showed. Discussion Points: Rationale… View more

Intervention
Author(s): Fausto Castriota , Armando Liso , Giancarlo Biamino , et al Added: 3 years ago
Carotid angioplasty and stenting (CAS) is becoming a frequent therapeutic strategy for approaching severe carotid obstructive disease and is now widely accepted as a less invasive technique that provides an attractive alternative for many patients, particularly those with significant co-morbidities.1–6 From a technical standpoint, the continuous evolution of carotid stent design increases the… View more

Intervention
Editorial

Article

Author(s): Angela Hoye Added: 3 years ago
It is my great honour to join Interventional Cardiology Review as Coronary Section Editor. In the modern era we are all increasingly busy and it is a pleasure to be part of a journal that helps to maintain an up-to-date knowledge of clinical practice. I practice as an Interventional Cardiologist in a univesrsity hospital in Hull, UK, and have a particular interest in undertaking complex coronary… View more

Prevention & Chronic Conditions